<DOC>
	<DOCNO>NCT00629590</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy AzaSite ophthalmic solution , 1 % sign symptom blepharitis .</brief_summary>
	<brief_title>Safety Efficacy Pilot Study AzaSite ( Azithromycin ) Subjects With Blepharitis</brief_title>
	<detailed_description />
	<mesh_term>Blepharitis</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>diagnosis moderate severe chronic posterior blepharitis female childbearing potential , nonpregnant nonlactating ocular surface surgery ( LASIK , refractive , etc . ) within past year unwilling discontinue use contact lenses study glaucoma unable unwilling withhold use lid scrub study serious systemic disease uncontrolled medical condition judgment investigator could confound study assessment limit compliance currently use preserve topical ocular medication ( exception unpreserved tear substitute ) time entry study study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>